Abstract: Amine compounds having activity against inflammation, fungi, unicellular parasitic microorganisms, and cancer are described. The compounds contain a monocyclic, bicyclic, or tricyclic aromatic ring having one, two, or three ring nitrogen atoms.

Abstract: Compounds and compositions that deliver both uridine and ketoleucine are useful in treating disorders characterized by diminished muscle strength or diminished muscle lean mass. One such a compound is 5?-O-ketoleucyl-2?,3?-di-O-acetyluridine.

Abstract: 5?-O-Phenylacetyluridine effectively delivers both phenylacetate and uridine to a subject. It can be used to treat hepatic encephalopathy and genetic disorders of the hepatic nitrogen cycle.

Abstract: An imidazoquinoline compound having activity against inflammation, fungi, unicellular parasitic microorganisms, and cancer is described.

Abstract: 5?-O-(Acetoacetyl)-2?,3?-di-O-acetyluridine is useful in the treatment or prevention of disorders characterized by cerebral metabolic energy failure or diminished mitochondrial energy reserve capacity.

Abstract: The present invention relates to a composition, textile, and mask for reducing the inhalation of pollutants. The composition includes an aqueous solution of an inorganic iodide compound, a metal phthalocyanine, and a polymeric binder. The inorganic iodide can be cuprous iodide, the metal phthalocyanine can be iron phthalocyanine, and the polymeric binder can be polyvinylpyrrolidone or polyvinyl alcohol. This pollutant-inactivating composition neutralizes pollutants such as nitrogen dioxide, sulfur dioxide, ozone, volatile organic compounds and other unpleasant airborne agents, without requiring elevated temperatures or bulky canisters containing adsorbents. Optionally, a humectant can also be incorporated into the coating solution to retain moisture in the active filter matrix, which enhances the activity of the composition to inactivate oxidizing gases and other toxic constituents of air pollution.

Abstract: Uridine triacetate or other uridine prodrugs are used to treat genetic glycosylation disorders by administering them in an amount sufficient to raise plasma uridine in the patient to a level greater than 30 micromolar. They can be administered alone or in combination with a sugar whose transfer is defective in the glycosylation disorder being treated.

Abstract: Amine compounds having activity against inflammation, fungi, unicellular parasitic microorganisms, and cancer are described. The compounds contain a monocyclic, bicyclic, or tricyclic aromatic ring having one, two, or three ring nitrogen atoms.

Abstract: The present invention relates to a composition, textile, and mask for reducing the inhalation of pollutants. The composition includes an aqueous solution of an inorganic iodide compound, a metal phthalocyanine, and a polymeric binder. The inorganic iodide can be cuprous iodide, the metal phthalocyanine can be iron phthalocyanine, and the polymeric binder can be polyvinylpyrrolidone or polyvinyl alcohol. This pollutant-inactivating composition neutralizes pollutants such as nitrogen dioxide, sulfur dioxide, ozone, volatile organic compounds and other unpleasant airborne agents, without requiring elevated temperatures or bulky canisters containing adsorbents. Optionally, a humectant can also be incorporated into the coating solution to retain moisture in the active filter matrix, which enhances the activity of the composition to inactivate oxidizing gases and other toxic constituents of air pollution.

Abstract: The present invention relates to a composition, textile, and mask for reducing the inhalation of pollutants. The composition includes an aqueous solution of an inorganic iodide compound, a metal phthalocyanine, and a polymeric binder. The inorganic iodide can be cuprous iodide, the metal phthalocyanine can be iron phthalocyanine, and the polymeric binder can be polyvinylpyrrolidone or polyvinyl alcohol. This pollutant-inactivating composition neutralizes pollutants such as nitrogen dioxide, sulfur dioxide, ozone, volatile organic compounds and other unpleasant airborne agents, without requiring elevated temperatures or bulky canisters containing adsorbents. Optionally, a humectant can also be incorporated into the coating solution to retain moisture in the active filter matrix, which enhances the activity of the composition to inactivate oxidizing gases and other toxic constituents of air pollution.

Abstract: The present invention relates to a composition, textile, and mask for reducing the inhalation of pollutants. The composition includes an aqueous solution of an inorganic iodide compound, a metal phthalocyanine, and a polymeric binder. The inorganic iodide can be cuprous iodide, the metal phthalocyanine can be iron phthalocyanine, and the polymeric binder can be polyvinylpyrrolidone or polyvinyl alcohol. This pollutant-inactivating composition neutralizes pollutants such as nitrogen dioxide, sulfur dioxide, ozone, volatile organic compounds and other unpleasant airborne agents, without requiring elevated temperatures or bulky canisters containing adsorbents. Optionally, a humectant can also be incorporated into the coating solution to retain moisture in the active filter matrix, which enhances the activity of the composition to inactivate oxidizing gases and other toxic constituents of air pollution.

Abstract: The invention relates to compositions comprising acyl derivatives of cytidine and uridine. The invention also relates to methods of treating hepatopathies, diabetes, heart disease, cerebrovascular disorders, Parkinson's disease, infant respiratory distress syndrome and for enhancement of phospholipid biosynthesis comprising administering the acyl derivatives of the invention to an animal.

Abstract: The invention relates to compositions comprising 2?-deoxyribonucleosides. The invention also relates to methods of accelerating the healing of wounds, abrasions, cuts, incisions, and superficial burns induced by heat, sunlight, chemical agents, or infections, and methods for ameliorating the effects of aging of the epidermal tissues comprising administering the compositions of the present invention to an animal.

Abstract: The invention relates to compositions comprising acyl derivatives of cytidine and uridine. The invention also relates to methods of treating hepatopathies, diabetes, heart disease, cerebrovascular disorders, Parkinson's disease, infant respiratory distress syndrome and for enhancement of phospholipid biosynthesis comprising administering the acyl derivatives of the invention to an animal.

Abstract: The invention relates to compositions comprising acyl derivatives of 2′-deoxyribonucleosides. The invention also relates to methods of treating or preventing radiation, mutagen and sunlight-induced biological damage, and methods for improving wound healing and tissue repair, comprising administering the compositions of the present invention to an animal.

Abstract: The invention relates to compositions comprising acyl derivatives of cytidine and uridine. The invention also relates to methods of treating hepatopathies, diabetes, heart disease, cerebrovascular disorders, Parkinson's disease, infant respiratory distress syndrome and for enhancement of phospholipid biosynthesis comprising administering the acyl derivatives of the invention to an animal.

Abstract: The invention relates to compositions comprising acyl derivatives of 2′-deoxyribonucleosides. The invention also relates to methods of treating or preventing radiation, mutagen and sunlight-induced biological damage, and methods for improving wound healing and tissue repair, comprising administering the compositions of the present invention to an animal.

Abstract: The invention relates to compositions comprising acyl derivatives of 2′-deoxyribonucleosides. The invention also relates to methods of treating or preventing radiation, mutagen and sunlight-induced biological damage, and methods for improving wound healing and tissue repair, comprising administering the compositions of the present invention to an animal.

Abstract: The invention relates to compositions comprising acyl derivatives of cytidine and uridine. The invention also relates to methods of treating hepatopathies, diabetes, heart disease, cerebrovascular disorders, Parkinson's disease, infant respiratory distress syndrome and for enhancement of phospholipid biosynthesis comprising administering the acyl derivatives of the invention to an animal.

Abstract: The invention relates to compositions comprising acyl derivatives of cytidine and uridine. The invention also relates to methods of treating hepatopathies, diabetes, heart disease, cerebrovascular disorders, Parkinson's disease, infant respiratory distress syndrome and for enhancement of phospholipid biosynthesis comprising administering the acyl derivatives of the invention to an animal.